
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES116
A Cochrane review237 found a significant reduction in the risk of doubling of serum creatinine
concentration with A2RB compared to placebo/no treatment (3 studies, 3,251 patients):
RR 0.79 95% CI 0.67 to 0.93. Level 1++

[@2005]

